Exhibit 99.1 Treace Medical Concepts Reports First Quarter 2025 Financial Results PONTE VEDRA, Fla. – May 8, 2025 – Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty ® Procedures, today reported financial results for the first quarter ended March 31, 2025 Recent Highlights "We are pleased with the positive c ...

PONTE VEDRA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today reported financial results for the first quarter ended March 31, 2025. Recent Highlights Generated revenue of $52.6 million in first quarter 2025 representing growth of 3% over the same pe ...

NEW YORK, May 8, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI).Shareholders who purchased shares of TMCI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/treace-medical-concepts-inc-loss-submission-form-2/?id=147316&from=4CLASS PER ...

NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI). Shareholders who purchased shares of TMCI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/treace-medical-concepts-inc-loss-submission-form-2/?id=147118&from=3 ...

Core Viewpoint - Treace Medical Concepts, Inc. is facing a class action lawsuit due to alleged misleading statements and failure to disclose critical information regarding its business performance and product demand during the specified class period [3]. Group 1: Lawsuit Details - The class action lawsuit represents investors who purchased Treace Medical securities between May 8, 2023, and May 7, 2024 [1]. - Investors have until June 10, 2025, to file a lead plaintiff motion [1]. - The lawsuit claims that increased competition negatively impacted the demand for Treace Medical's core product, the Lapiplasty® 3D Bunion Correction System [3]. Group 2: Financial Impact - As a result of the competition, Treace Medical experienced a decline in revenue and was forced to expedite the development of an alternative product to osteotomy [3]. - The lawsuit alleges that the defendants made materially misleading representations about Treace Medical's business operations and future prospects, leading to investor damages when the true facts emerged [3]. Group 3: Legal Support - The Portnoy Law Firm offers complimentary case evaluations for investors seeking to recover losses and provides options for pursuing claims [2][4]. - The firm's founding partner has successfully recovered over $5.5 billion for aggrieved investors in the past [4].

NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Middle District of Florida against Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI), and certain of its former and current officers and/or directors (collectively, “Defendants”). The Class Action asserts claims under §§10(b) and 20(a ...

NEW YORK, May 6, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc." or the "Company") (NASDAQ: TMCI) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Treace Medical Concepts, Inc. investors who were adversely affected by alleged securities fraud between May 8, 2023 and May 7, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zl ...

If you purchased or acquired Treace Medical securities, and/or would like to discuss your legal rights and options please visit Treace Medical Concepts, Inc. Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com. According to the Complaint, Defendants made misrepresentations concerning the impact of competition on demand for, and utilization of, the Company's primary product, the Lapiplasty 3D Bunion Correction System. If you wish to ...

NEW YORK, May 5, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI).Shareholders who purchased shares of TMCI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/treace-medical-concepts-inc-loss-submission-form-2/?id=146608&from=4 CLASS PE ...

NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc." or the "Company") (NASDAQ: TMCI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Treace Medical Concepts, Inc. investors who were adversely affected by alleged securities fraud between May 8, 2023 and May 7, 2024. Follow the link below to get more information and be contacted by a member of our team: htt ...